uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Hurdles in therapy with regulatory T cells
Med Univ Gdansk, Dept Clin Immunol & Transplantol, PL-80952 Gdansk, Poland..
Stanford Sch Med, Dept Pediat Stem Cell Transplantat & Regenerat Me, Stanford, CA USA..
Ist Sci San Raffaele, IRCCS, DRI, I-20132 Milan, Italy..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
Show others and affiliations
2015 (English)In: Science Translational Medicine, ISSN 1946-6234, E-ISSN 1946-6242, Vol. 7, no 304, 304ps18Article in journal (Refereed) Published
Abstract [en]

Improper activation of the immune system contributes to a variety of clinical conditions, including autoimmune and allergic diseases as well as solid organ and bone marrow transplantation. One approach to counteract this activation is through adoptive therapy with regulatory T cells (T-regs). Efforts to manufacture these cells have led to good maunfacturing practice-compliant protocols, and T-reg products are entering early clinical trials. Here, we report the stance of the European Union Cooperation in Science and Technology Action BM1305, "Action to Focus and Accelerate Cell-based Tolerance-inducing Therapies-A FACTT," which identifies hurdles hindering T-reg clinical applications in Europe and provides possible solutions.

Place, publisher, year, edition, pages
2015. Vol. 7, no 304, 304ps18
National Category
Cell Biology
Identifiers
URN: urn:nbn:se:uu:diva-264052DOI: 10.1126/scitranslmed.aaa7721ISI: 000360943900002OAI: oai:DiVA.org:uu-264052DiVA: diva2:859031
Funder
EU, FP7, Seventh Framework Programme
Available from: 2015-10-05 Created: 2015-10-05 Last updated: 2017-12-01Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Berglund, David

Search in DiVA

By author/editor
Berglund, David
By organisation
Clinical Immunology
In the same journal
Science Translational Medicine
Cell Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 331 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf